Faculty profile

Tom Hobman

ResearcherCell BiologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.

Tom Hobman

Researcher

Cell Biology

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Principal investigator on 16 research grants (11 CIHR, 5 NSERC), most recently in 2021.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Peroxisomes Pathogenesis Transcriptomics Antivirals Coronavirus Emerging Viruses Sars Vaccines

Latest papers

FOXO1 transcription factor modulates airway epithelial responses to viral infection.
PloS one · 2026
Expanding knowledge of mosquito (Diptera: Culicidae) and California serogroup viruses distributions in the North American Arctic.
Journal of medical entomology · 2025
No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024).
Viral immunology · 2025

All 10 publications

Latest funding

Precision health IDEAS (Inclusion/Diversity/Equity/Accessibility/Sustainability) for NeuroHIV: disrupted immunometabolism in the brain
CIHR · 2024 · Co-investigator
$20,000
Cardiovascular Disease in Post COVID Condition: Taurine and ACE2 Probiotics as Potential Therapies
CIHR · 2024 · Co-investigator
$1,002,150
Functional analyses of pathogenicity determinants of SARS-Coronavirus-2 delta variant
CIHR · 2022 · Co-investigator
$96,270

All 33 grants and awards

10 publications.

FOXO1 transcription factor modulates airway epithelial responses to viral infection.

Daniel NM, Mann-Nüttel R, Shrestha Palikhe N, López-Orozco J, Hobman T, Forsythe P, Vliagoftis H

PloS one2026

DOI: 10.1371/journal.pone.0345169 PMID: 41931532

Expanding knowledge of mosquito (Diptera: Culicidae) and California serogroup viruses distributions in the North American Arctic.

Villeneuve CA, Snyman J, Snyman LP, Gouin GG, Jenkins E, Martinez V, Hobman T, Kumar A, Dusfour I, Lecomte N, Leighton PA

Journal of medical entomology2025

DOI: 10.1093/jme/tjaf130 PMID: 40999774

No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024).

Wallace HL, Wight J, Rzeszutek GJ, Jafri MS, Baz M, Dowding B, Flamand L, Hobman T, Jean F, Joy JB, Lang AS, MacParland S, McCormick C, Noyce R, Russell RS, Sagan SM, Snyman J, Bogoch II, Rasmussen AL, Rimoin AW, Kindrachuk J, Pan-Canadian Milk Study Network

Viral immunology2025

DOI: 10.1089/vim.2025.0029 PMID: 40474813

Longitudinal screening of retail milk from Canadian provinces reveals no detections of influenza A virus RNA (April-July 2024): leveraging a newly established pan-Canadian network for responding to emerging viruses.

Wallace HL, Wight J, Baz M, Dowding B, Flamand L, Hobman T, Jean F, Joy JB, Lang AS, MacParland S, McCormick C, Noyce R, Russell RS, Sagan SM, Snyman J, Rzeszutek GJ, Jafri MS, Bogoch I, Kindrachuk J, Rasmussen AL

Canadian journal of microbiology2025

DOI: 10.1139/cjm-2024-0120 PMID: 39332021

SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to inhibit nucleocytoplasmic transport.

Makio T, Zhang K, Love N, Mast FD, Liu X, Elaish M, Hobman T, Aitchison JD, Fontoura BMA, Wozniak RW

Molecular biology of the cell2024

DOI: 10.1091/mbc.e23-10-0386 PMID: 38507240

Special Issue of the 4th Symposium of the Canadian Society for Virology 2022.

Meier-Stephenson V, Evans D, Hobman T, Marchant D, Noyce R, Shmulevitz M

Viruses2023

DOI: 10.3390/v15071512 PMID: 37515198

Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2.

Nguyen L, McCord KA, Bui DT, Bouwman KM, Kitova EN, Elaish M, Kumawat D, Daskhan GC, Tomris I, Han L, Chopra P, Yang TJ, Willows SD, Mason AL, Mahal LK, Lowary TL, West LJ, Hsu SD, Hobman T, Tompkins SM, Boons GJ, de Vries RP, Macauley MS, Klassen JS

Nature chemical biology2022

DOI: 10.1038/s41589-021-00924-1 PMID: 34754101

HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response.

Joyce MA, Berry-Wynne KM, Dos Santos T, Addison WR, McFarlane N, Hobman T, Tyrrell DL

PLoS pathogens2019

DOI: 10.1371/journal.ppat.1007949 PMID: 31374104

Dual Catalytic Synthesis of Antiviral Compounds Based on Metallocarbene-Azide Cascade Chemistry.

Atienza BJP, Jensen LD, Noton SL, Ansalem AKV, Hobman T, Fearns R, Marchant DJ, West FG

The Journal of organic chemistry2018

DOI: 10.1021/acs.joc.8b00222 PMID: 29663810

West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.

van Marle G, Antony J, Ostermann H, Dunham C, Hunt T, Halliday W, Maingat F, Urbanowski MD, Hobman T, Peeling J, Power C

Journal of virology2007

DOI: 10.1128/jvi.02422-06 PMID: 17670819

Something wrong or missing on this profile? Suggest a correction

Tom Hobman

Research

Latest papers

Latest funding

FOXO1 transcription factor modulates airway epithelial responses to viral infection.

Expanding knowledge of mosquito (Diptera: Culicidae) and California serogroup viruses distributions in the North American Arctic.

No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024).

Longitudinal screening of retail milk from Canadian provinces reveals no detections of influenza A virus RNA (April-July 2024): leveraging a newly established pan-Canadian network for responding to emerging viruses.

SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to inhibit nucleocytoplasmic transport.

Special Issue of the 4th Symposium of the Canadian Society for Virology 2022.

Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2.

HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response.

Dual Catalytic Synthesis of Antiviral Compounds Based on Metallocarbene-Azide Cascade Chemistry.

West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.

Precision health IDEAS (Inclusion/Diversity/Equity/Accessibility/Sustainability) for NeuroHIV: disrupted immunometabolism in the brain

Cardiovascular Disease in Post COVID Condition: Taurine and ACE2 Probiotics as Potential Therapies

Functional analyses of pathogenicity determinants of SARS-Coronavirus-2 delta variant

Probing the role of mechanical rigidity in viral xrRNAs as the key to preventing their degradation by host RNases

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

COVID-19 Variant Supplement - Therapeutic approaches to SARS-CoV-2 and other pathogenic coronaviruses

Deciphering the impact of aging and inflammation on neurocognitive impairments in people with Post-Acute Sequelae of COVID-19 (PASC)

Functional analyses of pathogenicity determinants of SARS-Coronavirus-2 delta variant

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

Functional analyses of pathogenicity determinants of emerging SARS-Coronavirus-2 variants

Frequent collaborators

Sonya MacParland

Louis Flamand

Craig McCormick

Maya Shmulevitz

David Marchant

Harissios Vliagoftis

Isaac Bogoch

Guido van Marle

Christopher Power

Vanessa Meier-Stephenson

Christopher Power

Paul Forsythe

David Evans